Athira Pharma, Inc. (ATHA) Tops Q2 EPS by 4c

Athira Pharma, Inc. (NASDAQ: ATHA) reported Q2 EPS of ($0.70), $0.04 better than the analyst estimate of ($0.74).

For earnings history and earnings-related data on Athira Pharma, Inc. (ATHA) click here.

You May Also Be Interested In

• Bernstein SocGen Group Upgrades X-Fab Silicon Foundries SE (XFAB:FP) to Outperform
• HSBC Downgrades Hermes International (RMS:FP) (HESAY) to Hold
• Jefferies Starts Trastor Real Estate Investment Co (TRASTOR:GA) at Buy